Is ENSC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENSC. It does not provide personalized investment advice.

ENSC (Ensysce Biosciences, Inc. Common Stock) Stock Analysis - Financials

Ensysce Biosciences, Inc. Common Stock (ENSC) is a publicly traded Healthcare sector company. As of July 15, 2026, ENSC trades at $0.28 with a market cap of $4.49M and a P/E ratio of -0.07. ENSC moved -2.09% today. Year to date, ENSC is -68.33%; over the trailing twelve months it is -86.19%. Its 52-week range spans $0.23 to $10.96. Rallies surfaces ENSC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ENSC's key financials?

ENSC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ENSC recently traded at $0.28. Market cap is $4.49M. P/E ratio is -0.07. Revenue is $5.07M.

ENSC Key Metrics

Key financial metrics for ENSC
Metric	Value
Price	$0.28
Market Cap	$4.49M
P/E Ratio	-0.07
EPS	$-3.98
Dividend Yield	0.00%
52-Week High	$10.96
52-Week Low	$0.23
Volume	487.68K
Avg Volume	0
Revenue (TTM)	$5.07M
Net Income	$-10.18M
Gross Margin	0.00%

ENSC Analyst Consensus

ENSC analyst coverage data. Average price target: $0.00.

Common questions about ENSC

What are ENSC's key financials?: ENSC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ENSC recently traded at $0.28. Market cap is $4.49M. P/E ratio is -0.07. Revenue is $5.07M.
Is ENSC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENSC. It does not provide personalized investment advice.